Rerefined model

PDB 2VIO|dpdb_4edgpbva

Rerefined model

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Program
PHENIX 2.0_5824
Model type
Multiconformer
Purpose
Refinement
Atoms
2,189
Residues
248
Protein chains
1
Alternate-location fraction
0.4%
Ligands
ACT, L1O

Evaluations

R-work
0.230
R-free
0.284
Clashscore
6.9

Macromolecules

The same in every model of this entry.

Entity 1
MoleculeChainsLengthOrganismUniProtDetails
UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B253
  • ConstructCATALYTIC DOMAIN, RESIDUES 179-431
  • MutationsYES

Data

L0 Raw
L1 Processed
L2 Models
L3 Evaluations